Laboratory Diagnosis by Genotyping

  • Irene Belmonte
  • Luciana Montoto
  • Francisco Rodríguez-Frías
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1639)

Abstract

Alpha-1 antitrypsin (AAT) genotyping is useful to confirm the clinical diagnosis of AAT deficiency and determine the specific allelic variant. Genotyping is the reference standard procedure for identifying rare allelic variants and characterizing new variants. It is also useful when there is a discrepancy between the patients’ AAT levels and their phenotypes. AAT genotype is determined by an allele-specific genotyping assay for the S, Z, and Mmalton variants and by exome sequencing.

Key words

Alpha-1 antitrypsin laboratory diagnosis Alpha-1 antitrypsin genotyping Alpha-1 antitrypsin deficiency Alpha-1 antitrypsin allele-specific genotyping Alpha-1 antitrypsin exome sequencing LightCycler Melting curves 

Notes

Acknowledgments

This study was supported in part by a grant from Fundación Catalana de Pneumología (FUCAP 2015) and by funding from Grifols to the Catalan Center for Research in Alpha-1 antitrypsin deficiency of the Vall d’Hebron Research Institute in Vall d’Hebron University Hospital, Barcelona, Spain.

References

  1. 1.
    Molina J, Flor X, García R, Timiraos R, Tirado-Conde G, Miravitlles M (2011) The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting. Ther Adv Respir Dis 5:237–243CrossRefPubMedGoogle Scholar
  2. 2.
    Rodriguez-Frias F, Miravitlles M, Vidal R, Camos S, Jardi R (2012) Rare alpha-1-antitrypsin variants: are they really so rare? Ther Adv Respir Dis 6:79–85CrossRefPubMedGoogle Scholar
  3. 3.
    Costa X, Jardi R, Rodriguez F, Miravitlles M, Cotrina M, Gonzalez C et al (2000) Simple method for alpha1-antitrypsin deficiency screening by use of dried blood spot specimens. Eur Respir J 15:1111–1115CrossRefPubMedGoogle Scholar
  4. 4.
    Rodriguez F, Jardí R, Costa X, Cotrina M, Galimany R, Vidal R et al (2002) Rapid screening for alpha1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood specimens. Am J Respir Crit Care Med 166:814–817CrossRefPubMedGoogle Scholar
  5. 5.
    Vidal R, Blanco I, Casas F, Jardí R, Miravitlles M (2006) Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency. Arch Bronconeumol 42:645–659CrossRefPubMedGoogle Scholar
  6. 6.
    Miravitlles M, Herr C, Ferrarotti I, Jardi R, Rodriguez-Frias F, Luisetti M et al (2010) Laboratory testing of individuals with severe alpha1-antitrypsin deficiency in three European centres. Eur Respir J 35:960–968CrossRefPubMedGoogle Scholar
  7. 7.
    Belmonte I, Montoto L, Miravitlles M et al (2016) Rapid detection of Mmalton α1-antitrypsin deficiency allele by real-time PCR and melting curves in whole blood, serum and dried blood spot samples. Clin Chem Lab Med 54:241–248CrossRefPubMedGoogle Scholar
  8. 8.
    Belmonte I, Barrecheguren M, López-Martínez RM, Esquinas C, Rodríguez E, Miravitlles M, Rodríguez-Frias F (2016) Application of a diagnostic algorithm for the rare deficient variant mmalton of alpha-1-antitrypsin deficiency: a new approach. Int J Chron Obstruct Pulmon Dis 11:2535–2541CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Ferrarotti I, Scabini R, Campo I, Ottaviani S, Zorzetto M, Gorrini M, Luisetti M (2007) Laboratory diagnosis of alpha1-antitrypsin deficiency. Transl Res 150(5):267–274CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  • Irene Belmonte
    • 1
    • 2
  • Luciana Montoto
    • 3
  • Francisco Rodríguez-Frías
    • 1
    • 4
  1. 1.Liver Pathology Unit, Departments of Biochemistry and MicrobiologyHospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona (UAB)BarcelonaSpain
  2. 2.Vall d’Hebron Institut de Reserca (VHIR)BarcelonaSpain
  3. 3.Molecular Biology DepartmentHospital de Niños Pedro ElizaldeBuenos AiresArgentina
  4. 4.CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Nacional de Salud Carlos IIIMadridSpain

Personalised recommendations